FEVR: Robust growth across all regions, with U.S. momentum and diversification fueling future gains
Strong H1 performance with 8% revenue growth, led by the U.S. and U.K. recovery, and expanding non-tonic portfolio. U.S. partnership with Molson Coors is driving distribution and marketing gains, with profitability set to rise as local production ramps up.Based on Fevertree Drinks PLC [FEVR] H1 202…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.